Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized phase III adjuvant study of S-1 plus oxaliplatin versus UFT plus leucovorin in stage IIIb colorectal cancer
jRCT1080221040Phase 3Completed
- Sponsor
- Taiho Pharmaceutical Co., Ltd.
- Start
- Mar 2010
- Modality
- Small Molecules, Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of tegafur, oxaliplatin, tegafur + uracil and folinic acid in colorectal adenocarcinoma (2 arms), sponsored by Taiho Pharmaceutical Co., Ltd. Started Mar 2010; status: completed.
02
Drugs
tegafuroxaliplatintegafur + uracilfolinic acid
03
Conditions
colorectal adenocarcinoma
Beyond the preview
Go deeper on jRCT1080221040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080221040.